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Abstract 
 
Synthesis and Stabilities of Mononuclear Iron (II) Dicarbonyls derived 
from Neutral NNS Ligands: Structural Models of the Apo-active Site of 
Mono-Iron (Hmd) Hydrogenase 
 
Keren Arunothayam Thomas Muthiah, M.A. 
The University of Texas at Austin, 2014 
 
Supervisor: Michael J. Rose  
 
Herein is described the syntheses and characterization of iron dicarbonyl complexes 
derived from tridentate ortho-substituted Schiff base pyridine/thioether ligands (RNNS) 
and [Fe(CO)4(Br)2]. Two general synthetic routes are reported for the isolation of such 
iron carbonyls. First, metalation of RNNS ligands within Et2O at room temperature 
affords the complex species of type [(RNNS)Fe(CO)2Br][Fe(CO)3(Br)3]. Alternatively, 
metalations of RNNS (R = CH3, OCH3) at low temperature (−78 °C) in CH2Cl2/MeCN 
mixtures with [Fe(CO)4(Br)2] afford complexes of formula [(RNNS)Fe(CO)2Br]Br. 
Reactions under similar conditions with more sterically demanding ligands [R = 
quinoline (Q), chlorophenyl (ClPh)] afford a complex salt of the form 
[(RNNS)Fe(CO)2Br][Fe(CO)3(Br)3]. Complexes have been characterized using X-ray 
crystallography, IR spectroscopy and low temperature 1H NMR spectroscopy. 
Photostability of the complexes has been studied using UV-vis and solution IR 
spectroscopies. Relevance to the apo-active site of mono-iron hydrogenase is discussed. 
 vii 
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I.A. Introduction to the Hydrogenase Enzyme 
 
Introduction to The Third Hydrogenase  
 
Hydrogenases are enzymes found in archaea and bacteria that catalyze either the 
production or utilization of dihydrogen (H2). These enzymes have captured the 
interest of the scientific and industrial circle as they use dihydrogen as the reducing 
agent. The two most commonly known hydrogenases are the [FeFe]-hydrogenase, 
which contains iron-sulfur clusters and [NiFe]-hydrogenase, which contains nickel 
and iron-sulfur clusters. The [NiFe]-hydrogenase also includes hydrogenases that 
contain selenium, [NiFeSe]-hydrogenase (Figure I.1). 
 
 
 
  
 
 
 
 
 
Figure I.1 The active sites of the Hydrogenases (A) [NiFe]-hydrogensase from 
Desulfovibrio gigas. (B) [FeFe]-hydrogenase from Clostridium pasteurianum and 
Desulfovibrio desulfuricans. (C) [Fe]-hydrogenase from Methanocaldococcus Jannaschii 
(Figure credits to Shima et al.).1 
 
 
In the 1980s, a third type of hydrogenase was found to be the mononuclear iron 
hydrogenase (also known as H2-forming methylenetetrahydromethanopterin 
dehydrogenase (Hmd)). This hydrogenase does not contain any nickel, or iron-sulfur 
clusters and therefore is also known as the ‘iron-sulfur-cluster free’ hydrogenase. This 
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enzyme is sensitive to light (prone to bleaching)  and dioxygen and therefore is grown 
under red light. Additionally, Hmd is only constitutively expressed under nickel-
limiting conditions, which prevents the production of the otherwise preferable [NiFe] 
hydrogenase. Hmd catalyzes the reversible reduction of methenyl-
tetrahydromethanopterin (methenyl-H4 MPT+) with H2 to methylene-H4 MPT and H+ 
(Scheme I.1). This reaction is an intermediate step in the production of methane from 
carbon dioxide.1 
 
 
 
 
 
 
 
Scheme I.1 Reaction catalyzed by Hmd, i.e. [Fe]-hydrogenase. 
 
Crystal structure of the active site of [Fe]-Hydrogenase 
For many years, the structure of the active site of Hmd was a matter of intense debate 
due to difficulty in obtaining pure enzyme and crystallization of the protein. NMR 
spectroscopy and mass spectrometry were initially used to characterize Hmd, as well as 
its active site cofactor. For several years it was believed that this hydrogenase did not 
contain any metal site and that it was a purely organic active site. Subsequently it was 
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discovered that the activity of the enzyme was dependent on the presence of an iron 
cofactor and the crystal structure of the enzyme was reported. Mössbauer spectroscopy 
was used to identify the oxidation state of metal center. It was concluded that the metal 
was either low spin Fe(0) or Fe(II)2 and that the iron center in the active site was not 
redox-active. 
 In 2008, Shima et al. reported the first crystal structure of the active site of Hmd 
with the Fe (II) center. The coordination of the central metal is as follows: iron is 
coordinated 
 
 
 
 
 
 
Figure I.2 Originally proposed model (A) and revised model (B) of the active site [Fe]-
Hydrogenase. 
coordinated to Cys176 sulfur, two CO molecules, and an unknown ligand in the equatorial 
plane of the Fe(II) center octahedron. The nitrogen from 2-pyrinidol/2-pyridone is in the 
pyramid. The sixth position is occupied by a solvent molecule (H2O), which was 
suggested to be the binding site of substrate H2 (Figure I.2.A).3 
 
 
 
 
 
Figure I.3 The active site on [Fe]-Hydrogenase.  
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The proposed structure A was revised and the new structure B is widely accepted. In this, 
the iron is octahedrally coordinated to the sulfur of Cys176, two CO molecules, an acyl 
unit from the 2-pyridinol 6-formylmethyl group and the nitrogen of the same moiety, the 
solvent/substrate is present trans to the acyl unit (Figure I.3). Fe(II) is in the low spin 
state and the acyl unit carries a negative charge, while possibly also acting as a strong π-
acceptor.  
 
Biogenesis of the Active Site of Hmd 
 For many decades it was believed that the only known naturally occurring 
bioorganometallic compound was Vitamin B12. It was the only known compound to have 
a stable metal-carbon bond other than a carbonyl ligand. Now the only other known 
biological complex to have this unique feature is the [Fe]-Hydrogenase, and this distinct 
acyl unit is like no other bond yet found in biology.  
 
 
 
 
  
 
 
 
 
 
Figure I.4 The predicted biosynthesis of FeGP. (Picture credits to Shima et al.)4 
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  Shima et al. have investigated the biogenesis of the active site of Hmd using 
stable-isotope labeling experiments (Figure I.4).4 Labeling studies show that the methyl 
group in the para-position relative to the alcohol in the pyridinol ring has been derived 
from the methyl group of the methionine. The biogenesis of the two CO ligands and acyl 
unit were traced using labeling experiments employing acetates and pyruvates containing 
appropriate substitution with 13C. These studies revealed that the ligands were not derived 
from these precursors. Later 13CO2 was used to in similar studies using different mass 
spectrometry techniques. These studies indicated that CO2 was the precursor of these 
three ligands in Hmd. However, the exact mechanism of the formation of the unique acyl 
bond still remains unclear. The authors proposed a mechanism based on the formation of 
the acetyl-nickel bond from the acetyl-CoA synthase/decarbonylase of acetogens and 
methanogens.   
 To further understand the structural implications and the role of each 
component of the active site, synthetic modeling becomes an attractive approach. 
Synthetic modeling of the active site gives the flexibility to incorporate a few or all of the 
features of the active site and then study their individual contributions to the stability or 
the property of the active site. 
 
1.4. References 
(1)  Shima, S.; Pilak, O.; Vogt, S.; Schick, M.; Stagni, M. S.; Meyer-Klaucke, W.; 
Warkentin, E.; Thauer, R. K.; Ermler. U. Science 2008, 321, 25. 
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 (2) Wang, X.; Li, Z.; Zeng, X.; Luo, Q.; Evans, D. J.; Pickett, C. J.; Liu, X. Chem. 
Commun. 2008, 3555. 
(3) Hiromoto, T.; Ataka, K.; Pilak, O.; Vogt, S.; Stagni, M. S.; Meyer-Klaucke, W.; 
Warkentin, E.; Thauer, R. K.; Shima, S.; Ermler. U. FEBS Lett. 2009, 583, 585. 
(4) Schick, M.; Xie, X.; Ataka, K.; Kahnt, J.; Linne, U.; Shima, S. J. Am. Chem. Soc. 
2012, 134, 3271. 
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I.B. Literature Survey: Synthetic Models of Mono-Iron Hydrogenase present in the 
Literature 
 
Ferracyclic carbamoyl complexes related to the active site of [Fe]-Hydrogenase1 
  
 The active site of the [Fe]-hydrogenase or H2-forming 
methylenetetrahydromethanopterin dehydrogenase (Hmd) contains only one iron(II) in 
the active site. There is much interest in the unique array of ligands, which bind to the 
metal center to form the active site. This consists of two cis-carbonyl groups, a chelating 
pyridine–acyl ligand, a sulfur of Cys176 and a solvent molecule (presumably H2O). 
Pickett et al. have reported ferracyclic complexes with carbamoyl group as a substitute 
for acyl unit.  The general scheme for the preparation for the carbamoyl unit is given in 
Scheme I.2. 
 
 
 
Scheme I.2 Generalized mechanism for metallocyclic carbamoyl formation. 
 
The initial reaction with of 2-aminopyridine with [Fe(CO)4Br2] forms the carbomyl unit. 
This complex contains a labile solvent molecule, which can be replaced by more strongly 
coordinating ligands such as PR3 (R = Me, Ph). The replication of the active-site with a 
replacable solvent coordination site was sucessfully charaterized by X-ray 
crystallography. Attempts to introduce a hydroxyl group, using the ligands 1a, 1a’ and 
1b, at the 6-position of the pyridine were unsucessful (Figure I.5).  
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Figure I.5 Oxygen-functionalized aminopyridines. 
 
 On the contrary, reaction with 2,6-diaminopyridine, which has an additional 
nitrogen pendant base at the 6-position, undergoes reaction similar to 2-aminopyridine.  
Scheme I.3 Synthesis of complex 3. 
 
The structure of compound 3 was characterized by X-ray crystallography. This 
compound is structurally similar to the active site as it contains an alternative pendant 
base in the place of hydroxyl group at the 6-position (Scheme I.3). 
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Biomimetic Models for the Active Site of [Fe]-Hydrogenase Featuring an 
Acylmethyl(hydroxymethyl)pyridine Ligand2 
 Li-Cheng Song et al. have synthesized novel model complexes of [Fe]-
Hydrogenase containing acylmethyl (hydroxymethyl) pyridine ligand by the following 
scheme (Scheme I.4). 
 
Scheme I.4 Synthesis of Model Complexes 5− 7 via Intermediate Complex 4. 
 
The synthetic route proposed uses the formally Fe(−2) salt of [Na2Fe(CO)4 (1,4-
dioxane)1.5], which undergoes oxidative addition during the nucleophilic substitution with 
2-(4-MeC6H4SO3CH2)-6-HOCH2C5H3N in MeCN to give the Fe(0) complex salt [Na(2-
CH2-6-HOCH2C5H3N)Fe(CO)4] (4). In the presence of Br2 or I2, in situ CO migratory 
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insertion followed by coordination of its hydroxyl group and oxidation of the metal site 
result in the formation of the model complexes [(2-COCH2-6-HOCH2C5H3N)Fe(CO)2X] 
(5, X = Br; 6, X = I). Finally complexes 5 and 6 were treated with KSCOMe in MeCN to 
give the final model complex [(2-COCH2-6-HOCH2C5H3N)Fe(CO)2(SCOMe)] (1) via 
replacement of bromide or iodide in 5  and 6  by MeCOS− , so as to resemble the active 
site with the presence of sulfur in the coordination sphere.  
The complex formation was monitored by in situ IR spectroscopy. There are 
significant changes in the νCO absorption bands versus the starting material Na2[Fe(CO)4], 
intermediate complex 4 (which was too unstable to be isolated), and product 6. 
Na2[Fe(CO)4] in MeCN has νCO absorption bands at 1760 (vs), 1866 (w), 1886 (m), and 
1915 (w) cm−1  gradually diminished, and after 10 min upon the addition 2-(4-
MeC6H4SO3CH2)-6-HOCH2C5H3N, which indicates the completion of the reaction with 
the formation of complex 4. The newly formed complex 4 has a very strong band at 1885 
cm−1 and a middle band at 2001 cm−1. The formation of complex 6 upon the addition of I2 
exhibits a strong band at 2030 cm−1, a medium band at 1967 cm−1, and a weak band at 
1671 cm−1 which can be assigned to the two cis-oriented terminal carbonyl ligands and 
one acyl ligand replacing the prior mentioned absorption bands of complex 4.  
Complexes 5-7 were structurally characterized by elemental analysis, spectroscopy, 
and X-ray crystallography. The geometric comparison of complex 7 to that of the active 
site shown above shows that the model complex matches the active site parameters very 
closely. The weakly coordinated hydroxyl group structurally mimics not only the 
hydroxyl group on the pyridine of the active site but also the H2O, which is at the 6- 
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Figure I.6 Geometric parameters for the natural enzyme with FeGP-cofactor (left) and model 
(right): distance in Å, angles in °. 
 
coordinating position. Thus complexes 5-7 will contribute in further understanding the 
catalytic mechanism of the active site.  
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Reversible Dimerization of Mononuclear Models of [Fe]-Hydrogenase3 
Novel Fe-Hydrogenase models were synthesized via five-coordinate and dimer 
complexes. This work by Xile Hu et al. is the continuation of a previously reported  
 
 
 
 
 
 
Scheme I.5 Reactions of 8 with sodium aryl thiolate. 
five-coordinate complex synthesized by his group. Interestingly, this complex contains an 
open coordination site which does did not react with H2 under ambient conditions. This 
work describes the equilibrium between the dimeric and monomeric complexes. Scheme 
I.5 gives the reaction of [Fe (2-CH2CO-6-MeOC5H3N)(CO)3I] (8) with (4-NO2-C6H4)SNa 
results in a dinuclear complex [{Fe(2-CH2CO-6-MeOC5H3N)(CO)2{S-(4-NO2-C6H4)}}2] 
(9a) which was characterized by IR spectroscopy, X-ray crystallography in the solid state 
and NMR spectroscopy in solution. Similar reaction was carried out with various 
substitutes R1 and R2 to yield complexes 9b and 9c. These three complexes 9a, 9b and 9c 
exist as monomeric complexes in solution 9a’, 9b’ and 9c’. In the presence of CO a new 
tris(carbonyl) complex [Fe(2-CH2CO-6-MeOC5H3N)(CO)3{S-(4-NO2-C6H4)}] (10a) is 
formed (Scheme I.6).  
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Scheme I.6 Reaction of 9a’ with CO. 
 
 Further reaction to isolate similar products like 9a’ was carried out (Scheme I.7). 
Reaction of (2-CF3-C6H4)SNa with complex 8 results in the formation of [Fe(2-CH2CO-
6-MeOC5H3N)(CO)2{S-(2-CF3-C6H4)}] (9d’) and [Fe(2-CH2CO-6-MeOC5H3N)(CO)3{S-
(2-CF3-C6H4)}] (10d). 
 
 
 
 
  
 
Scheme I.7 Reaction of 8 with (2-CF3-C6H4)SNa. 	  
These complexes have been characterized using NMR spectroscopy. The ratio of 9d’ to 
10d was 5:4 at -30°C. The two complexes are involved in a fast exchange reaction with 
the transfer of CO.  
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To isolate pure 9d’ an alternative route (Scheme I.8) was attempted which 
involved the reaction of [Fe(2-CH2CO-6-MeOC5H3N)(CO)2(CH3CN)2]BF4 (11) with (2-
CF3C6H4)SH in the presence of NEt3 at -30°C which yielded 9d’. The solution of 9d’ has 
a half-life of 0.5 h.  
 
 
 
 
 
Scheme I.8 Reaction of 11 with (2-CF3-C6H4)SH and NEt3.	  
 
 A similar reaction was carried out to synthesize 9e, [{Fe(2-CH2CO-6-
MeOC5H3N)(CO)2{S-(tBu)}}2]. This complex which is unstable even at -30 °C in 
solution yielding 9e’ was characterized only by IR and NMR spectroscopies. The 
following Scheme I.9 illustrates its synthesis.   
 
 
 
 
 
Scheme I.9 Reactions of 11 with tBuSH and NEt3. 
 
Notably, complexes 9a’- 9e’ still do not react with H2 under ambient conditions. It 
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hydrogenase may play a very important role. Thus, these complexes serve a limited role 
as reactivity models of [Fe]-hydrogenase.  
 
Synthesis and Reactivity of Mononuclear Iron Models of [Fe]-Hydrogenase that 
Contain an Acylmethylpyridinol Ligand4 
 Xile Hu et al. have also reported mono-iron centered complexes, which model the 
[Fe]-Hydrogenase with ligated by an acylmethylpyridinol ligand.  Complex 12 was 
prepared by the reaction of  [(2-CH2CO-6-tBuOC5H3N)Fe(CO)3I] with the dropwise 
addition of lithiated 2-tert-butoxy-6-methylpyridine to [Fe(CO)5], followed by treatment 
of I2. The resulting complex 12 is further reacted with NaS(2,6-Me2C6H3) to yield a five-
coordinate complex [2-CH2CO-6-tBuOC5H3N)Fe(CO)2{S-(2,6-Me2-C6H3)}] (13). 
 
 
 
 
 
Figure I.7 Complexes 12, 13 and 14. 
 
Complex 13 was structurally characterized by X-ray crystallography. This 
complex also shows absence of reactivity in the presence of H2, which was monitored by 
NMR spectroscopy. However, the sixth coordination site can be occupied by a third CO 
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tBuOC5H3N)Fe(CO)3{S-(2,6-Me2-C6H3)}]. This CO in complex 14 is labile in the 
presence of N2, regenerating complex 13 (Figure I.7).  
Complex 13 was further treated with CF3COOH/CH3CN to give a six-coordinate 
ionic complex (Figure I.8), [(2-CH2CO-6-tBuOC5H3N)Fe(CO)2(CH3CN)2]+(CF3COO)− 
(15) which was characterized by NMR and elemental analysis.  
 
 
 
 
Figure I.8 Complexes 15 and 16. 
 
 
Deprotection of the tBu group in complex 13 is difficult due to the instable 
product formed. Therefore a new route to deprotect the tBu group in complex 12 was 
sought. The reaction of 12 with an excess of Me3SiI (3.5 equiv) followed by the addition 
of H2O resulted in the formation of complex 16 (Figure I.8), [(2-CH2CO-6-
HOC5H3N)Fe(CO)3I], which was characterized by IR and NMR spectroscopies.  
  
 
 
 
 
Figure I.9 Complexes 17-22. 
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Complex 17 was prepared by the treatment of 16 with AgBF4 in CH3CN, giving 
[(2-CH2CO-6-HOC5H3N)Fe(CO)2-(CH3CN)2][BF4], (17). This complex gave two intense 
νCO peaks in IR spectra (in both solid and solution in CH3CN). Further reaction using this 
complex by treating 17 with a series of thiols and thiophenols in the presence of NEt3 at 
−30 °C to give the targeted thiolate complexes 18-22 (Figure I.9). Complexes 18, 19, 21 
and 22 were only identified using IR spectroscopy as they were too unstable in solution at 
−30°C to obtain an NMR spectrum. Reaction of complex 20 with H2, monitored by NMR 
did not show any reaction. This result is possibly consistent with the essential role of 
methenyl-H4MPT+ for H2 activation by [Fe]-hydrogenase. In the presence of CO, 
conversion of 18 and 20 to tricarbonyl complexes [(2-CH2CO-6-HOC5H3N)Fe(CO)3{S-
(2,6-Me2-C6H3)}] (18a) and [(2-CH2CO-6-HOC5H3N)Fe(CO)3{S-(C6F5)}] (20a), Figure 
I.10, was not complete (33% for 18 and 38% for 20).  
 
 
 
 
 
 
 
 
 
Figure I.10 Complexes 18a, 20a and 23.	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When 17 was treated with 2-mercaptoethanol in the presence of NEt3, [(2-
CH2CO-6-HOC5H3N)Fe(CO)2(SCH2CH2OH)] (23) was produced. The complex was 
characterized by IR spectroscopy.  
To model the acetic acid extracted FeGP cofactor complex 16 was treated with 
CH3COOAg in CH2Cl2. This yielded complex 24, which in the presence of CH3CN exists 
in equilibrium with 24a in the ratio of 2:1 (Figure I.11).   
 
 
 
 
 
 
 
Figure I.11 Complexes 24 and 24a.	  
 
The reaction of 24 with C6F5SH/NEt3 in CH2Cl2 results in the five coordinate 
complex 20. The same reaction in the presence of 20 equivalents of CH3CN was carried 
resulting in the same product 20 this indicates that it exists only as a five coordinate as 
the iron center does not bind CH3CN. The lack of reactivity of these new complexes with 
H2 suggests that in nature [Fe]-Hydrogenase possibly requires the presence of methenyl-
H4MPT+ and enzymatic environment for H2 activation.  
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Scope of the present work 
There has been notable interest in synthetic modeling of the active site of [Fe]-
Hydrogenase in the past decade. The available synthetic models have a few of the 
following characteristics.  
• The iron source for these complexes initially is in the Fe(0) state, which is then 
oxidized to Fe(II) during the course of the reaction. However in biology it is 
likely that the only source of iron is present in the +2 oxidation state.   
• In order to make the acyl unit a strong base (e.g. n-BuLi) is used to abstract a 
proton. Therefore it is still not clear how the acyl unit is made in nature, as there 
are no similarly strong bases in biology.  
• The use of a primary amine (R-NH2) group to make the carbomoyl linkage, even 
though structurally similar to the active site, does not give insight into the bond 
formation mechanism of the acyl unit.  
 
Objectives:  
The objectives of this study are to make models of the apo-active site replicating some of 
the characteristics observed in biology as follows: 
• To make Hmd Apo-active site model complexes using Fe(II) as the metal site. 
This is achieved using [Fe(CO)4Br2] as the source for both iron and carbonyls.  
• To use ligands designed to facilitate the formation of the acyl unit with the 
addition of milder and more biologically relevant bases.  
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2-methyl-pyridine ligands can be a good tool to explore the role of methyl group 
at the 6-position of the pyridine and then this group will facilitate making the acyl 
unit. 
• To structurally characterize theses complexes using X-ray crystallography.  
• To study the stability of the complex using UV-vis and IR spectroscopy.  
N L
6-methyl-pyridine ligands 
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II. Results and Discussion 
Synthesis and X-ray Structures 
Metallation reactions using [Fe(CO)4Br2] and the un-substituted NNS ligand (i.e. 
HNNS) were preformed in THF, MeCN and also 1:2 combination of THF/MeCN. Care 
was taken to eliminate oxidation and therefore these reactions were done in N2 
atmosphere. Reactions were done with and without the presence of AgBF4 to study the 
influence of the coordinating and non-coordinating counter ion on the formation of the 
desired product. The desired products of these reactions were the dicarbonyl iron 
complexes, [Fe(HNNS)(CO)2Br]X, X = Br, BF4. The result of the above two reactions 
(both in the presence and absence of AgBF4) resulted in a purple colored complex, which 
was later characterized using X-ray crystallography (Figure II.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure II.1 ORTEP diagrams (50% ellipsoids) of the dication of the bis-ligated complex 
[(HNNS)2Fe](BF4)2. 
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This neutral, diamagnetic complex has an Fe(II) center and two HNNS occupying all the 
coordinating sites around the metal center with two BF4 units acting as the counterions. 
This complex was also characterized in solution state to monitor its stability using 1H 
NMR (Figure IV.4.). Similar complexes have since been prepared using different 
substituents on the NNS ligands. Stability studies of these complexes have led us to 
believe that the choice of solvents and the reaction temperature may have a major effect 
on the outcome of the product. 
 
Two different reaction conditions were then chosen to bring about the synthesis of 
the desired product, [Fe(HNNS)(CO)2Br]X. First, a non-coordinating solvent, Et2O, was 
chosen which could completely dissolve both the starting metal complex (the stability of 
the starting salt was also tested in ether, the carbonyl peaks were retained in solution as in 
the solid state) and all of the RNNS ligand. These reactions were performed under 
ambient atmosphere and at room temperature. The second set of conditions involved 
using DCM with or without the coordinating solvent, MeCN, in the ratio of 5:1 at low 
temperatures (−70 °C) to prevent the loss of CO ligands from the complex. 
 
Reactions in Et2O 
The first metalation reactions in ether were tried using the HNNS and HNNMeS 
resulting in the formation of dark precipitate, green and brown respectively, in each case, 
which could not be characterized by X-ray crystallography. Other RNNS ligands (R = 
Me, MeO, PhCl) yielded an orange/green precipitate, which had three carbonyl stretches. 
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The crystal structures of these complexes revealed that they were dicarbonyl mono-iron 
complexes with a [Fe(CO)3Br3]− counterion (Shown in Figure IV.2).     
1) 
 
 
 
 
 
 
 
 
 
 
 
2) 
 
 
 
 
 
 
 
 
 
 
 
 
3) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure II.2 Crystal structure and connectivity of (1) [(MeNNS)Fe(CO)3(Br)][Fe(CO)3(Br)3], (2) 
[(OMeNNS)Fe(CO)2Br] [Fe(CO)3(Br)3] and (3) [(PhClNNS)Fe(CO)2Br] [Fe(CO)3(Br)3]. 
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The above shown complexes had high disorder (1 and 3) in the crystal structure due to 
the counterion. Complex 3 (Figure II.3) was also derived with another counterion 
[(PhClNNS)Fe(CO)2Br][Fe(Br)4] (3a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure II.3 ORTEP diagrams (50% ellipsoids) of the complex species 
[(PhClNNS)Fe(CO)2Br][Fe(Br)4] (3a). 
 
The change in the counter ion from the structure [Fe(CO)3Br3]− to [FeBr4]− is believed to 
have occurred because of the storage of the crystals at room temperature. This change 
was gradual (1 week) and very slow resulting in the loss of CO from the counter ion and 
oxidation of Fe(II) to Fe(III).  
 
Reactions in DCM/MeCN 
Reactions using the second set of conditions (low temperature and DCM/MeCN) 
yielded the dicarbonyl complexes with bromide as the counter ion in two cases, when 
RNNS R = Me and MeO (Figure II.4). When bulkier substituent (R = PhCl, Q) were used 
the resulting product had [Fe(CO)3Br3]− as the counterion, suggesting that in the case of 
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bulkier R groups the iron tricarbonyl counter ion has higher stability as compared to the 
bromide. Reaction using the HNNS under this second set of conditions did not yield any 
product that could be characterized by X-ray crystallography. Product from the reaction 
of HNMeNS yielded very few crystals, which were characterized using X-ray 
crystallography.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure II.4 Connectivity structure of [(OMeNNS)Fe(CO)2Br](Br).CH2Cl2. 
   
 
 All of the above-mentioned diamagnetic complexes were characterized using 1H 
NMR and IR spectroscopies. The preference of one counterion to another in the low 
temperature DCM/MeCN reactions maybe attributed to the bulkiness of the substituents 
	   27 
at the 6-position of the pyridine ring. Scheme II.1 below shows the possible equilibrium 
between for the formation of the complex with either Br− or [Fe(CO)3Br3]−. 
  
 
 
 
 
2 
 
 
 
 
 
  
      R = Me, MeO, Q, PhCl 
 
 
 
 
 
 
Scheme II.1. Equilibrium in solution for the reaction in DCM/MeCN. 
 
Photolysis of Iron Carbonyl complexes using UV/vis Spectroscopy 
 
In order to assess the influence of the substituents at the sixth position of the 
pyridine of the dicarbonyl complexes of [Fe(RNNS)(CO)2(Br)][Fe(CO)3(Br)3], UV/vis 
spectroscopy was performed. These studies were conducted both in the presence and 
absence of light at room temperature and under ambient atmosphere.  The dicarbonyl iron 
complexes are stable at very dilute conditions in the absence of light but in the presence 
of light there was a loss of CO from the complex to form dibromide complexes in 
solution was observed. Very dilute solutions (0.1 to 1 mM) of the dicarbonyl complexes 
complex salts with R = Me, OMe, Q and ClPh were prepared in MeCN at low 
temperature (−30 °C). 
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1)  
 
 
 
 
 
 
2) 
 
 
 
 
 
 
3) 
 
 
 
 
Figure II.5.Changes in UV/vis absorption spectra upon photolysis of 
[(RNNS)Fe(CO)3(Br)][Fe(CO)3(Br)3] , 1) R= Me, 2) R = MeO 3) R = PhCl with broadband, 
AM1.5 white light (100 mW/cm2). 
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Absorption measurements were preformed at systematic time intervals to follow the 
increase in the absorbance of the complex at 460 nm, indicating the formation of the 
dibromides from the dicarbonyl complex with the release of CO (Time vs. Absorbance 
plots are shown in Figure IV.15. to IV.17.)  
The substituents on the 6-position of the pyridine ring effect the photostability of 
stability with R = OMe being the slowest to lose CO (t½ = 22.6 min) and R = ClPh being 
the fastest (t½ = 8.5 min), with R= Me (t½ = 12.0 min) appearing moderately stable in 
comparison. The substituents according to their photostability are OMe > Me > ClPh 
(Figure II.6). Another type of NNS ligand the QNNS which was also used to make the 
dicarbonyl complex salts was studied, [[(QNNS)Fe(CO)3(Br)][Fe(CO)3(Br)3], whose 
photostability is comparable with that of the methyl substituted complex (t½ = 12.7 min). 
 
 
 
 
 
 
 
 
 
 
Figure II.6. Photoconversion of the cationic dicarbonyl species (as indicated) to the Fe(II) 
dibromides via dissociation of CO ligands. Inset: Expanded view of the same plot at short time 
periods. Photolysis conditions: MeCN, 100 mW/cm2 white light, 298 K. 
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Since the effect of the counterion on the stability of the complex was unknown, the 
bromide complex of the methyl-substituted dicarbonyl, [Fe(MeNNS)(CO)2(Br)]Br, was 
subjected to the same UV/vis studies and conditions stated above. The results were 
distinct with the iron complex counterion, [Fe(CO)3Br3]−, being more sensitive to light of 
the two different anions, Br − and [Fe(CO)3Br3]−. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure II.7. Top: Changes in UV/vis absorption spectra upon photolysis of 
[(MeNNS)Fe(CO)3(Br)]Br with broadband, AM1.5 white light (100 mW/cm2). Bottom: Kinetic 
trace following the absorbance at λ = 460 nm as indicator of formation of the dibromide species. 
Blue lines represent the 95% confidence interval of the exponential fit to the data, and red lines 
represent the 95% prediction band. (Filled Circles – Time intervals in the presence of light. 
Empty Circles – Time intervals in the absence of light). 
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Figure II.7 shows that the dicarbonyl complex with the bromide counter ion is much 
more stable in light (t½ = 128 min) as compared to the same methyl complex with the 
iron counter ion (t½ = 12.0 min). The reasons for this higher stability may only be 
attributed to the presence of more available bromide ions for the formation of dibromide 
in the case of the iron counter ion, [Fe(CO)3Br3]−. 
 
Monitoring Photostability of Iron Carbonyls Complexes using Solution IR 
Spectroscopy 
To monitor the loss of CO from the metal center, solution infrared studies were 
done on [Fe(MeNNS)(CO)2(Br)] Br. This complex eliminates the interference of the CO 
groups on the counter ion and has a longer t½, which is preferable since these IR studies 
were done at much higher concentrations as compared to the UV/vis studies.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure II.8. Solution IR spectra recorded during photoconversion of [Fe(MeNNS)(CO)2(Br)]Br to 
[Fe(MeNNS)(CO)2(Br)2] in MeCN. Photolysis conditions: ~100 mM, 100 mW/cm2 white light, 
298 K. Inset: Solid state IR spectrum of [Fe(MeNNS)(CO)2(Br)] Br 
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The figure above (Figure II.8) shows the slow systematic loss of CO from the complex. 
The figure shows changes in the CO concentration (at 2100-2000 cm−1) of the complex 
while the Schiff base (at 1500 cm−1) of the ligand is intact, indicating that the complex is 
only losing CO ligands with the ligand still bond to the central metal atom.   
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III. Materials and Methods 
 
General Procedures and Reagents 
The starting materials for the preparation of the iron salt and the ligands were 
obtained from Acros Organics or Sigma Aldrich and were used without further 
purification. [Fe(CO)4Br2] and some of the NNS ligands namely (HNNS),(MeNNS) and 
(QNNS) were prepared according to literature.1,2,3,4 These methods have been given in 
detail below. HPLC grade solvents were purchased from EMD, Fisher, Macron or 
J.T.Baker, and dried through an alumina column system (Pure Process Technology). 
Deuterated solvents were purchased from Cambridge Isotopes or Acros Organics.  
 
Characterization of RNNS ligands and Iron Carbonyl complexes 
All synthesized RNNS ligands and complexes were characterized using 1H NMR 
and solid-state IR spectroscopies. 1H NMR spectra for the ligands were collected on a 
Varian DirecDrive 400 MHz spectrometer and all chemical shifts were referenced to 
TMS. High-resolution mass spectroscopy was used in cases where the ligand was 
obtained as a mixture of the desired product and starting material.  
The metal complexes were structurally characterized using X-ray crystallography. 
The data was collected either on a Rigaku AFC12 diffractometer with a Saturn 724+ 
CCD or on a Nonius Kappa CCD diffractometer using a Bruker AXS Apex II detector, 
both using a graphite monochromator with MoKα radiation. Reduced temperatures were 
maintained using an Oxford Cryostream low temperature device. Data reduction were 
performed using the Rigaku Crystal Clear version 1.40.2. Structures were solved by 
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direct methods using SIR973 and refined by full-matrix least-squares on F2 with 
anisotropic displacement parameters for the non-H atoms using SHELXL-97.4. Structure 
analysis was aided by use of the programs PLATON985 and WinGX.6. 1H NMR spectra 
of the iron carbonyl complexes were recorded on a 500 MHz Varian Inova instrument 
fitted with a variable temperature apparatus. The stability in solution was also confirmed 
using 1H NMR spectroscopy at low temperatures (−5 °C ∼ −30 °C).  
  The presence of Schiff bases in the ligands and carbonyls in the metal complexes 
were confirmed using solid state Infrared spectroscopy (Bruker Alpha spectrometer 
equipped with a diamond ATR crystal).  
 
Ligand Synthesis  
NMeNS. 2-(methylthio)-N-(1-(pyridin-2-yl)ethylidene)aniline.  
2-(methylthio)aniline (0.500 g, 3.59 mmol) was diluted in 5 mL acetic acid, and to this 
solution was added 2-acetylpyridine (0.434 g, 3.59 mmol) in 5 mL  AcOH. Next, a slurry 
of ZnCl2 (0.489 g, 3.59 mmol) in 5 mL of AcOH was added, and the reaction refluxed for 
1 h to generate an orange solution (when hot). Upon cooling a yellow solid forms, which 
was collected by filtration and washed with several portions of Et2O. The solid was then 
dissolved in CH2Cl2 (25 mL) and washed 2× in a separatory funnel with 0.25 M K2C2O4, 
and 2× with water. The organic layer was dried over Na2SO4 and evaporated to dryness 
by rotary evaporation to afford a yellow oil. Yield: 0.49 g (56%). Selected IR bands (ν in 
cm−1): 3052 w, 2919 w, 1635 s, 1578 m, 1565 m, 1466 s, 1434 s, 1301 m, 993 w, 965 w, 
780 vs, 737 vs, 649 w, 621 m. 1H NMR in CDCl3 (δ in ppm from TMS): 8.66 (d, J = 4 
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Hz, 1H), 8.39 (d, J = 8 Hz, 1H), 7.79 (t, J = 7.2, 1H), 7.36 (dt, J = 6.4 Hz, 1H), 7.25 (d, J 
= 2.4 Hz, 1H), 7.14 (m, 2H), 6.72 (d, J = 7.2 Hz, 1H), 2.37 (s, 3H), 2.34 (s, 3H). HRMS 
calcd: 241.0799, 242.0878, 243.0956; found: 241.0802, 242.0878, 243.0959. 
 
OMeNNS. 1-(6-methoxy-2-pyridyl)-N-(2-methylsulfanylphenyl)methanimine.  
A batch of 6-methoxy-2-pyridinecarboxaldehyde (2.00 g, 14.6 mmol) was dissolved in 20 
mL of MeOH. To this stirred solution was added a solution of 2-(methylthio)aniline (2.03 
g, 14.6 mmol) in 15 mL of MeOH. The solution was heated to reflux temperature for 2 h, 
at which point the solution was cooled to ambient temperature and solvent evaporated 
under a stream of N2 gas. The resulting tacky solid was gently triturated 2× with Et2O to 
yield an orange solid. Selected IR bands (ν in cm−1): 1623 w, 1587 m, 1567 s, 1462 s, 
1439 s, 1321 m, 1138 w, 800 vs, 750 vs, 725 vs, 635 w, 538 m. 1H NMR in CDCl3 (d 
from TMS): 8.44 (s, 1H), 7.90 (d, J = 7.2 Hz, 1H), 7.68 (t, J = 7.2 Hz, 1H), 7.23 (br, 1H), 
7.16 (br, 1H), 7.08 (br, 1H), 6.82 (d, J = 8.4 Hz, 1H), 6.75 (br, 1H), 4.00 (s, 3H), 2.47 (s 
br, 3H). HRMS calcd: 257.0749, 258.0827, 259.0905; found: 257.0756, 258.0833, 
259.0903. NMR analysis indicated unreacted (~30%) aldehyde that was not separated by 
fractional crystallization or chromatography. The mixture was used in subsequent 
metalations. 
 
ClPhN,N,SMe. N-((6-(4-chlorophenyl)pyridn-2-yl)methylene)-2-(methylthio)aniline. 
6-(4-chlorophenyl)-2-pyridine carboxaldehyde (0.500 g, 2.30 mmol) was suspended in 10 
mL of MeOH, upon the addition of a solution of 2-methylthioaniline (0.574 g, 2.30 
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mmol) in 10 mL of MeOH, the color of the solution changes from colorless to a bright 
yellow while forming a hazy solution. This mixture was refluxed for 2 h, during which it 
turned to a clear solution. On being cooled to room temperature, the reaction mixture 
precipitates the fluffy greenish yellow ligand. The solvent was evaporated using rotavap. 
The resulting solid was washed with ether (10 mL) to remove excess starting materials to 
afford a yellow sample of the ligand, analytically pure in the solid state. In the 1H NMR it 
shows a mixture of ligand peaks and the hydrolyzed product peaks. Yield: 0.64 g (63%). 
Selected IR bands (ν in cm−1): 1592 m, 1570 m, 1495 m, 1426 m, 1317 w, 1163 m, 1033 
s, 930 m, 804 vs, 745 vs, 677 w, 663 w. 1H NMR in CDCl3 (δ in ppm from TMS): 8.67 
(s, 1H), 8.29 (d, J = 8 Hz, 1H), 8.01 (d, J = 8.8 Hz, 2H), 7.89 (m, 3H), 7.79 (d, J = 7.6 
Hz, 1H), 7.48 (m, 2H), 7.35 (b, 1H), 7.12 (b, 1H), 6.73 (1H), 2.47 (s, 3H). 
 
Synthesis of Metal Complexes  
Tetracarbonyldibromoiron(II) [Fe(CO)4Br2 ] 
In 100 mL DCM, 3 mL (23 mmol) of [Fe(CO)5] was dissolved at RT. This solution was 
then kept at -40 °C. A solution of Br2 (1.5 mL, 29 mmol) in 20 mL DCM was taken in a 
25 mL Schlenk flask. This was then added drop-wise using a cannula to the [Fe(CO)5] 
solution. A bright orange precipitate was formed. The reaction mixture was stirred for 1-
1.5 h and warmed to RT. The color of the resulting precipitate is red/orange. The solvent 
was removed using short path/vacuum distillation and a dark red/brown precipitate was 
collected. This was washed with pentane and was then dissolved in minimal amounts of 
DCM and recrystallized by vapor diffusion of pentane at −20 °C. The crystals were 
	   37 
characterized by IR spectroscopy. Selected IR bands (ν in cm−1): 2158 cm−1, 2110 cm−1, 
2091 cm−1 and 2059 cm−1.  
 
[(HNNS)2Fe](BF4)2   
At room temperature, to a stirred solution of 1 equiv of HNNS (100 mg, 0.438 mmol) in 
10 mL of MeCN was added 2 mL of THF containing 1 equiv of [Fe(CO)4(Br)2] (118 mg, 
0.438 mmol). Addition of iron carbonyl immediately generated a dark violet color that 
was indefinitely stable under ambient conditions. To isolate the BF4 salt of the complex, 
1 equiv of AgBF4 (85 mg, 0.438 mmol) in 2 mL of THF was added; although no color 
change was observed, a turbid solution was generated (AgBr) and the resulting mixture 
was stirred overnight, and then filtered twice through Celite. Vapor diffusion of Et2O at 
room temperature afforded violet blocks suitable for X-ray diffraction. Yield: 65 mg 
(21%). Selected IR bands (ν in cm−1): 1604 w, 1585 w, 1477 m, 1306 w, 1162 w, 1029 
vs, 916 m, 775 s, 765 s, 750 s, 606 m, 516 s, 417 w. 1H NMR (500 MHz) in CD3CN, δ 
from TMS (ppm): 10.18 (s 2H), 8.58 (d, J = 8 Hz, 2H), 8.34 (d, J = 4 Hz, 2H), 8.02 (t, J = 
4 Hz, 2H), 7.82 (m, 6H), 7.75 (t, J = 12 Hz, 2H), 7.38 (t, J = 4 Hz, 2H), 2.14 (s, 6H). 
Elemental Analysis, calcd: C 45.38, H 3.81, N 8.14; found: C 45.29 H 3.77 N 8.27. 
 
General Procedure for [(RNNS)Fe(CO)2Br][Fe(CO)3(Br)3] 
Iron tetracarbonyl bromide (1 equiv) was dissolved in dry Et2O to give a bright red 
solution, which was stirred until homogenous. To this solution was slowly added a 
solution of the RNNS (1 equiv) in dry Et2O. Upon the addition of the ligand, there was an 
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immediate color change along with precipitation of the product. This mixture was stirred 
for 30 min, after which it was filtered and the precipitate was set up for recrystallization 
in acetonitrile with vapor diffusion of Et2O at −20°C.  
 
[(MeNNS)Fe(CO)2Br][Fe(CO)3(Br)3] 
(E)-1-(6-methylpyridin-2-yl)-N-(2-(methylthio)phenyl)methanimine (50 mg, 0.2065 
mmol) in 5 mL Et2O (yellow solution) was added to a red solution of iron tetracarbonyl 
bromide (67mg, 0.2065 mmol) in 5 mL Et2O. An immediate color change to orange-red 
with the formation of precipitate was observed. The mixture was stirred for 30 min and 
the crude product was collected by gravity filtration under ambient atmosphere. The 
resulting precipitate was a blend of orange and green. The product was recrystallized to 
yield red-orange crystals. Yield: 50 mg (30%). Selected IR bands (ν in cm−1): 2092 m, 
2075 s, 2033 vs, 1411 w, 1237 w, 798 m, 773 m, 621 vs, 569 vs, 511.7 s, 442 w. 1H 
NMR (500 MHz) in CD3CN at −25°C, δ from TMS (ppm): 9.68 (s, 1H), 8.30 (d, J = 4 
Hz, 1H), 8.09 (m, 2H), 7.92 (d, J = 4 Hz, 1H), 7.82 (t, J = 4 Hz, 1H), 7.67 (d, J = 4 Hz, 
1H), 3.03 (s 3H, pyCH3), 2.64 (s 3H, S-CH3). 
 
[(MeONNS)Fe(CO)2Br][Fe(CO)3(Br)3] 
(E)-1-(6-methoxypyridin-2-yl)-N-(2-(methylthio)phenyl)methanimine (50 mg, 0.1935  
mmol) was metallated with a solution of iron tetracarbonyl bromide ( 63 mg, 0.1935 
mmol) in 10 mL Et2O. An immediate color change to orange-red with the formation of 
precipitate is observed. The mixture was stirred for 30 min and the crude product was 
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collected by gravity filtration under ambient atmosphere. The resulting precipitate was a 
blend of orange and green. Recrystallization afforded orange-red rod shaped crystals. 
Yield 50 mg (31%). Selected IR bands (ν in cm−1): 2095 m, 2081 m, 2032 vs, 1593 w, 
1561 w, 1483 m, 1243 w, 1192 w, 797 m, 572 s, 518 m. NMR (500 MHz) in CDCN3 at 
−5°C, δ from TMS (ppm): 9.66 (s, 1H), 8.32 (br, 1H), 8.21 (br, 1H), 7.82 (br, 1H), 7.75 
(t, J = 4 Hz, 1H), 7.67 (d, J = 4 Hz, 1H), 4.22 (s, 3H), 2.64 (s, 3H). 
  
[(ClPhNNS)Fe(CO)2Br][Fe(CO)3(Br)3] 
(E)-1-(6-(4-chlorophenyl)pyridin-2-yl)-N-(2-(methylthio)phenyl)methanimine (50 mg, 
0.1477 mmol) in 5 mL Et2O was metallated with iron tetracarbonyl bromide (48 mg, 
0.1477 mmol) in 5 mL Et2O. An immediate color change to orange-red with the 
formation of precipitate is observed. The mixture was stirred for 30 min and the crude 
product is collected by gravity filtration under ambient atmosphere. The resulting 
precipitate was a blend of orange powder. The product was recrystallized to yield red-
orange crystals. Yield 43 mg (34%).  Selected IR bands (ν in cm−1): 2095 m, 2067 m, 
2034 s, 2025 vs, 1600 w, 1254 w, 1095 m, 966 w, 760 m, 621 s, 581 s, 437 w. IR bands 
of the crystallized [Fe(CO)3Br3]− complex : 2092 m, 2070 m, 2033 s, 2025 s, 1614 w, 
1253 w, 1094 m, 967 m, 768 m, 619 m, 580 s, 439 w. NMR (500 MHz) in CDCN3 at 5 
°C, δ from TMS (ppm): 9.79 (s, 1H), 8.34 (m, 2H), 8.27 (br, 1H), 7.86 (m, 2H), 7.75 (m, 
4H), 7.75 (m, 4H), 7.58 (d, J = 4 Hz, 1H), 7.53 (d, J = 4 Hz, 1H), 2.54 (s, 3H). 
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[(MeONNS)Fe(CO)2Br]Br 
Iron tetracarbonyl bromide (163 mg, 0.3870 mmol) was dissolved in 3 mL of dry DCM at 
-75 °C under N2 atmosphere. A yellow solution of MeONNS (100 mg, 0.3870 mmol) in 3 
mL dry DCM was cooled to −75 °C and then transferred through cannula to the above 
solution. This reaction was stirred for 10 min to yield a green-red solution. On the 
addition of dry MeCN (3 mL) via cannula, the color of the solution turned clear red. 
Recrystallization at −25 °C yielded very few crystals with good diffraction and a green-
purple precipitate, presumably of the dibromide and the bis-ligated complex.  
 
[(ClPhNNS)FeBr2]  
A solution of ClPhNNS (50 mg, 0.148 mmol) in 3 mL of dry DCM under N2 condition is 
transfer through cannula to a solution of iron tetracarbonyl bromide, [Fe(CO)4Br2], (48 
mg, 0.148 mmol) in 3 mL dry DCM kept at −75 °C under N2 conditions. The color of the 
reaction mixture changes from red to orange. MeCN (3 mL) is added to this through 
cannula, which changes the color to red orange. The resulting mixture was kept at −20 °C 
for several days which resulted in the formation of small amount of green crystals. 
Selected IR bands (ν in cm−1): 3035 m, 1620 m, 1598 m, 1092 m, 832 s, 811 s, 522 m, 
475 m.  
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IV. Spectroscopic Data 
 
NMR of NNS Ligands 
 
 
 
 
Figure IV.1. 1H NMR spectrum (400 MHz) of NMeNNS obtained in CDCl3 at 25 °C. 
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Figure IV.2. 1H NMR spectrum (400 MHz) of MeONNNS obtained in CDCl3 at 25 °C. 
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Figure IV.3. 1H NMR spectrum (400 MHz) of PhClNNNS obtained in CDCl3 at 25 °C. 
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NMR of Iron Complexes 
 
 
 
 
 
 
 
Figure IV.4. 1H NMR spctrum (500 MHz) of [(HNNS)2Fe](BF4)2 obtained in CD3CN at 
25 °C. 
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Figure IV.5. 1H NMR spectrum (500 MHz) of [(MeNNS)Fe(CO)2Br][Fe(CO)3(Br)3] 
obtained in CD3CN at -25 °C. 
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Figure IV.6. 1H NMR spectrum (500 MHz) of [(MeONNS)Fe(CO)2Br][Fe(CO)3(Br)3] 
obtained in CD3CN at -5 °C. 
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Figure IV.7. 1H NMR spectrum (500 MHz) of [(PhClNNS)Fe(CO)2Br][Fe(CO)3(Br)3] 
obtained in CD3CN at 5 °C. 
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IR Spectra of NNS Ligands 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure IV.8. Solid state IR spectrum of NMeNNS (298 K, ATR crystal). 
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Figure IV.9. Solid state IR spectrum of MeONNNS (298 K, ATR crystal). 
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Figure IV.10. Solid state IR spectrum of PhClNNNS (298 K, ATR crystal). 
 
 
 
 
 
 
 
 
 
 
 
	   52	  
 
IR Spectra of Iron Complexes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure IV.11. Solid state IR spectrum of [Fe(CO)4(Br)2] (298 K, ATR crystal). 
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Figure IV.12. Solid state IR spectrum of [(MeNNS)Fe(CO)3(Br)][Fe(CO)3(Br)3] (298 K, 
ATR crystal). 
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Figure IV.13. Solid state IR spectrum of [(MeONNS)Fe(CO)3(Br)][Fe(CO)3(Br)3] (298 K, 
ATR crystal). 
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Figure IV.14. Solid state IR spectrum of [(PhClNNS)Fe(CO)3(Br)][Fe(CO)3(Br)3] (298 K, 
ATR crystal). 
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Kinetic Trace for the Iron Carbonyl Complexes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure IV.15. [(MeNNS)Fe(CO)3(Br)][Fe(CO)3(Br)3], kinetic trace following the 
absorbance at λ = 460 nm as indicator of formation of the dibromide species. Blue lines 
represent the 95% confidence interval of the exponential fit to the data, and the red lines 
represent the 95% prediction band. (Shaded circles – time intervals in the presence of 
light. Un-shaded circles – time intervals in the absence of light). 
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Figure IV.16. [(MeONNS)Fe(CO)3(Br)][Fe(CO)3(Br)3], kinetic trace following the 
absorbance at λ = 460 nm as indicator of formation of the dibromide species. Blue lines 
represent the 95% confidence interval of the exponential fit to the data, and the red lines 
represent the 95% prediction band. (Shaded circles – time intervals in the presence of 
light. Un-shaded circles – time intervals in the absence of light). 
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Figure IV.17. [(PhClNNS)Fe(CO)3(Br)][Fe(CO)3(Br)3], Kinetic trace following the 
absorbance at λ = 460 nm as indicator of formation of the dibromide species. Blue lines 
represent the 95% confidence interval of the exponential fit to the data, and the red lines 
represent the 95% prediction band. (Shaded circles – time intervals in the presence of 
light. Un-shaded circles – time intervals in the absence of light). 
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Summary 
 
1) Metalation reactions involving neutral NNS ligands and Fe(II) tetracarbonyl dibromide 
starting salt  using two different reaction conditions resulted in the formation of the 
desired complex with their characteristic counter ion.  
 
2) The identity of the counterion varies depending on the reaction conditions and the 
substituents at the sixth position of the pyridine ring of the NNS ligand. For the low 
temperature DCM/MeCN reactions less bulkier substituents R= Me, MeO the counter ion 
X = Br while for R = Q, PhCl, X = [Fe(CO)3 Br3].  
 
3) The dicarbonyl complexes are light sensitive and the varying photostabilities are due 
to the substituents, concentration and solvent conditions.  
 
4) The iron dicarbonyls exhibit some structural similarity to the apo-active site of mono-
iron hydrogenase, and may provide a useful template for future studies into the 
biogenesis of the unique iron-acyl unit found in the native enzyme. 
 
5. Preliminary studies attempting acyl unit formation on [(MeNNS)Fe(CO)Br]+ with more 
mild bases (t-BuOK, bulky phenoxides, Ph3P=CH2 and CH3COO−) did not yield any 
conversion to the acyl species. Either no reaction or decarbonylation at the metal center 
was observed.  
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